Annual Accounts Receivable:
$36.54M+$12.46M(+51.70%)Summary
- As of today, AUPH annual accounts receivable is $36.54 million, with the most recent change of +$12.46 million (+51.70%) on December 31, 2024.
- During the last 3 years, AUPH annual accounts receivable has risen by +$21.13 million (+137.08%).
- AUPH annual accounts receivable is now at all-time high.
Performance
AUPH Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Accounts Receivable:
$30.73M-$9.36M(-23.35%)Summary
- As of today, AUPH quarterly accounts receivable is $30.73 million, with the most recent change of -$9.36 million (-23.35%) on September 30, 2025.
- Over the past year, AUPH quarterly accounts receivable has dropped by -$5.75 million (-15.77%).
- AUPH quarterly accounts receivable is now -26.44% below its all-time high of $41.77 million, reached on September 30, 2022.
Performance
AUPH Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
AUPH Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +51.7% | -15.8% |
| 3Y3 Years | +137.1% | -26.4% |
| 5Y5 Years | - | - |
AUPH Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +171.0% | -26.4% | +127.9% |
| 5Y | 5-Year | at high | >+9999.0% | -26.4% | >+9999.0% |
| All-Time | All-Time | at high | >+9999.0% | -26.4% | >+9999.0% |
AUPH Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $30.73M(-23.4%) |
| Jun 2025 | - | $40.09M(-0.6%) |
| Mar 2025 | - | $40.35M(+10.4%) |
| Dec 2024 | $36.54M(+51.7%) | $36.54M(+0.2%) |
| Sep 2024 | - | $36.48M(+42.9%) |
| Jun 2024 | - | $25.52M(-11.7%) |
| Mar 2024 | - | $28.91M(+20.0%) |
| Dec 2023 | $24.09M(+78.7%) | $24.09M(-36.5%) |
| Sep 2023 | - | $37.95M(+94.6%) |
| Jun 2023 | - | $19.50M(+2.4%) |
| Mar 2023 | - | $19.05M(+41.3%) |
| Dec 2022 | $13.48M(-12.5%) | $13.48M(-67.7%) |
| Sep 2022 | - | $41.77M(+129.9%) |
| Jun 2022 | - | $18.17M(-10.9%) |
| Mar 2022 | - | $20.40M(+32.4%) |
| Dec 2021 | $15.41M(>+9900.0%) | $15.41M(+57.1%) |
| Sep 2021 | - | $9.81M(+122.1%) |
| Jun 2021 | - | $4.42M(+272.2%) |
| Mar 2021 | - | $1.19M(>+9900.0%) |
| Dec 2020 | $0.00(-100.0%) | $0.00(-100.0%) |
| Mar 2020 | - | $2.94M(+699.7%) |
| Dec 2019 | - | $368.00K(-21.7%) |
| Sep 2019 | - | $470.00K(+89.5%) |
| Jun 2019 | - | $248.00K(-34.0%) |
| Mar 2019 | - | $376.00K(+73.3%) |
| Dec 2018 | $217.00K(+99.1%) | $217.00K(-71.4%) |
| Sep 2018 | - | $759.00K(+147.2%) |
| Jun 2018 | - | $307.00K(+36.4%) |
| Mar 2018 | - | $225.00K(+106.4%) |
| Dec 2017 | $109.00K(+26.7%) | $109.00K(-11.4%) |
| Mar 2017 | - | $123.00K(+43.0%) |
| Dec 2016 | $86.00K(+83.0%) | $86.00K(-12.2%) |
| Sep 2016 | - | $98.00K(+100.0%) |
| Jun 2016 | - | $49.00K(+4.3%) |
| Mar 2016 | - | $47.00K(0.0%) |
| Dec 2015 | $47.00K(-48.9%) | $47.00K(-14.5%) |
| Sep 2015 | - | $55.00K(-35.3%) |
| Jun 2015 | - | $85.00K(-25.4%) |
| Mar 2015 | - | $114.00K(+23.9%) |
| Dec 2014 | $92.00K(-13.2%) | $92.00K(+84.0%) |
| Sep 2014 | - | $50.00K(-56.1%) |
| Jun 2014 | - | $114.00K(+14.0%) |
| Mar 2014 | - | $100.00K(-5.7%) |
| Dec 2013 | $106.00K(+264.3%) | $106.00K(+34.5%) |
| Sep 2013 | - | $78.80K(-55.8%) |
| Jun 2013 | - | $178.20K(-3.2%) |
| Mar 2013 | - | $184.10K(+532.6%) |
| Dec 2012 | $29.10K | $29.10K(-86.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | $212.40K(-41.5%) |
| Jun 2012 | - | $362.90K(+536.7%) |
| Mar 2012 | - | $57.00K(+26.1%) |
| Dec 2011 | $45.20K(-21.3%) | $45.20K(-79.3%) |
| Sep 2011 | - | $218.80K(-2.2%) |
| Jun 2011 | - | $223.80K(+289.9%) |
| Dec 2010 | $57.40K(-85.7%) | $57.40K(-43.1%) |
| Sep 2010 | - | $100.80K(-13.6%) |
| Jun 2010 | - | $116.70K(-55.8%) |
| Mar 2010 | - | $263.90K(-46.8%) |
| Dec 2009 | - | $495.70K(-3.0%) |
| Sep 2009 | - | $510.80K(+390.2%) |
| Jun 2009 | - | $104.20K(-58.4%) |
| Mar 2009 | - | $250.30K(-38.5%) |
| Dec 2008 | $401.00K(-18.2%) | $406.70K(+49.5%) |
| Sep 2008 | - | $272.10K(-31.6%) |
| Jun 2008 | - | $397.90K(-14.9%) |
| Mar 2008 | - | $467.30K(-4.4%) |
| Dec 2007 | $490.40K(+229.8%) | $488.70K(+64.5%) |
| Sep 2007 | - | $297.10K(-16.8%) |
| Jun 2007 | - | $357.00K(-27.4%) |
| Mar 2007 | - | $491.50K(+23.7%) |
| Dec 2006 | $148.70K(-21.0%) | $397.20K(+19.9%) |
| Sep 2006 | - | $331.40K(-3.1%) |
| Jun 2006 | - | $341.90K(-5.6%) |
| Mar 2006 | - | $362.00K(-5.9%) |
| Dec 2005 | $188.30K(+35.1%) | $384.90K(-2.3%) |
| Sep 2005 | - | $393.90K(+30.4%) |
| Jun 2005 | - | $302.00K(-10.9%) |
| Mar 2005 | - | $338.90K(-2.3%) |
| Dec 2004 | $139.40K(-6.2%) | $346.90K(-9.6%) |
| Sep 2004 | - | $383.80K(+82.1%) |
| Jun 2004 | - | $210.80K(-23.4%) |
| Mar 2004 | - | $275.30K(-4.5%) |
| Dec 2003 | $148.60K(+2.1%) | $288.40K(+21.8%) |
| Sep 2003 | - | $236.70K(-36.1%) |
| Jun 2003 | - | $370.50K(-74.2%) |
| Mar 2003 | - | $1.44M(-35.5%) |
| Dec 2002 | $145.60K(-62.4%) | $2.23M(+18.6%) |
| Sep 2002 | - | $1.88M(-57.6%) |
| Jun 2002 | - | $4.43M(+1006.5%) |
| Mar 2002 | - | $400.70K(+195.1%) |
| Dec 2001 | $386.90K(+184.9%) | - |
| Nov 1999 | $135.80K(-30.5%) | $135.80K(-59.4%) |
| Aug 1999 | - | $334.50K(+64.4%) |
| May 1999 | - | $203.50K(-23.3%) |
| Feb 1999 | - | $265.20K |
| Nov 1998 | $195.30K | - |
FAQ
- What is Aurinia Pharmaceuticals Inc. annual accounts receivable?
- What is the all-time high annual accounts receivable for Aurinia Pharmaceuticals Inc.?
- What is Aurinia Pharmaceuticals Inc. annual accounts receivable year-on-year change?
- What is Aurinia Pharmaceuticals Inc. quarterly accounts receivable?
- What is the all-time high quarterly accounts receivable for Aurinia Pharmaceuticals Inc.?
- What is Aurinia Pharmaceuticals Inc. quarterly accounts receivable year-on-year change?
What is Aurinia Pharmaceuticals Inc. annual accounts receivable?
The current annual accounts receivable of AUPH is $36.54M
What is the all-time high annual accounts receivable for Aurinia Pharmaceuticals Inc.?
Aurinia Pharmaceuticals Inc. all-time high annual accounts receivable is $36.54M
What is Aurinia Pharmaceuticals Inc. annual accounts receivable year-on-year change?
Over the past year, AUPH annual accounts receivable has changed by +$12.46M (+51.70%)
What is Aurinia Pharmaceuticals Inc. quarterly accounts receivable?
The current quarterly accounts receivable of AUPH is $30.73M
What is the all-time high quarterly accounts receivable for Aurinia Pharmaceuticals Inc.?
Aurinia Pharmaceuticals Inc. all-time high quarterly accounts receivable is $41.77M
What is Aurinia Pharmaceuticals Inc. quarterly accounts receivable year-on-year change?
Over the past year, AUPH quarterly accounts receivable has changed by -$5.75M (-15.77%)